查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1368388

全球 HERG 篩檢市場 - 預測（~2030 年）

Global HERG Screening Market Research Report - Forecast to 2030
出版日期: | 出版商: Market Research Future | 英文 107 Pages | 訂單完成後即時交付

價格

在預測期內，全球 HERG 篩檢市場規模預計將以 12.50% 的複合年增長率成長。

區域考慮

北美市場在2022年引領市場（45.80%）。

歐洲市場在 2022 年佔據了健康的市場。 歐洲西部和東部地區佔據了大部分市場，被認為是主要貢獻者。

亞太市場預計將在 2023-2032 年呈現顯著發展。

本報告研究和分析了全球 HERG 篩檢市場，提供市場動態、區域和細分市場分析、公司簡介等。

目錄

第 1 章執行摘要

第二章市場介紹

第三章研究方法

第 4 章市場動態

  • 摘要
  • 促進因素
    • 新藥核准量增加
    • 心臟病盛行率不斷上升
  • 抑制因素
    • HERG 篩檢產品成本高
  • 機會
    • 尚未開發的市場
  • 新冠肺炎 (COVID-19-19) 的影響
    • 摘要
    • 對公司的影響
    • 對臨床試驗的影響

第五章市場因素分析

  • 供應鏈分析
    • 研發、設計
    • 製造業
    • 分佈
    • 行銷、銷售
    • 售後監控
  • 波特五力分析模型
  • 全球HERG篩檢市場的技術趨勢
    • HERG 服務外包趨勢日益明顯
    • 膜片鉗檢測的出現
    • 市場公司的策略舉措
  • 客戶需求分析
    • 摘要
    • HERG篩檢臨床試驗
    • 因果分析

第 6 章全球 HERG 篩檢市場：依類型

  • 摘要
  • 基因 KCNH2
  • 突變 KCNH2

第 7 章全球 HERG 篩檢市場：依離子通道劃分

  • 摘要
  • 電壓門控離子通道
  • 配體門控離子通道
  • 其他

第 8 章全球 HERG 篩檢市場：依應用分類

  • 摘要
  • 抗心律不整藥物
  • 抗精神病藥
  • 抗生素
  • 其他

第 9 章全球 HERG 篩檢市場：按地區

  • 摘要
  • 美國
    • 北美
    • 拉丁美洲
  • 歐洲
    • 西歐
    • 東歐
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳大利亞
    • 韓國
    • 亞太地區其他地區
  • 中東/非洲
    • 中東
    • 非洲

第10章競爭態勢

  • 摘要
  • 市場排名分析
  • 競爭基準測試
  • 主要發展與成長策略
    • 合作夥伴關係
    • 收購
    • 合作夥伴關係
  • 主要公司的財務矩陣與市場比率
    • 銷售額、營業利潤率
    • 研發費用

第十一章公司簡介

  • THERMO FISHER SCIENTIFIC INC.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
  • MERCK KGAA
  • EUROFINS DISCOVERX CORPORATION
  • ABCAM PLC.
  • CYPROTEX LIMITED
  • B'SYS GMBH
  • CREATIVE BIOARRAY
  • METRION BIOSCIENCES LTD
  • AURORA BIOMED INC.

第12章附錄

Product Code: MRFR/HC/8908-CR

Market Overview

The HERG Screening Market is anticipated to register a significant CAGR of 12.50% during the forecast period. The rising endorsement of imaginative medications and the ascent in coronary illness commonness are the major market drivers contributing the market development.

As coronary illness is common and the quantity of heart condition patients both ascents, the market is supposed to develop. The market is developing because of expanded Research and development exercises on the side of new item deliveries. Furthermore, it is extended that an ascent in the quantity of creative medication substance endorsements will uphold the market's development. The market is developing as a direct result of both the making of solutions for diseases and problems and the ascent of popularity for drug plans.

Because of the development in examples of cardiotoxicity, there has been a critical interest in screening materials utilized in drug creation. Customary testing techniques may not generally be preferable over HERG tests, yet they might be more secure and more effective when utilized on prescriptions. Cardiovascular medications are progressively having unfavorable aftereffects in patients with prior heart conditions. Cardiotoxicity is more normal in patients who have had malignant growth treatment or cardiovascular medical procedures. Subsequently, there is a rising interest in hardware and administrations that empower productive cardiotoxicity testing. The heart makes some harder memories completing typical capabilities and disseminating blood all through the body when there is cardiotoxicity. Cardiotoxicity thus expands the gamble of cardiomyopathy, which decreases the heart's ability to siphon blood.

Market Segmentation

The HERG Screening market segmentation, based on Type, includes Gene KCNH2 and Mutant KCNH2.

The HERG Screening market segmentation, based on Ion Channel, includes Voltage Gated and Ligand Gated. Based on Application the market is classified into Antiarrhythmic, Antipsychotic, Antibiotics, and Others.

Regional Insights

The North American HERG Screening Market led the market in 2022 (45.80%). At regular intervals, a resident of the US will encounter a myocardial dead tissue, as per the American School of Cardiology. In 2017, 356,460 Americans went through an out-of-clinic heart failure, and in 52% of those cases, crisis clinical benefits were called.

Europe HERG Screening market represented the sound market share in 2022. Europe's western and eastern regions make up most of the market for HERG screening and are both viewed as major contributors.

The Asia Pacific HERG Screening market is supposed to enroll in critical development from 2023 to 2032. A critical part of individuals in space has persistent heart conditions, and the occurrence of fiery problems is rising rapidly too.

Major Players

Major players in the HERG Screening market are Eurofins Scientific, Charles River Laboratories, Merck KGaA, Cyprotex Limited, Creative Bioarray, BSYS GmbH, Aurora Biomed, and Metrion Biosciences.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

  • 1.1 MARKET SYNOPSIS 14
  • 1.2 MARKET ATTRACTIVENESS ANALYSIS 15

2 MARKET INTRODUCTION

  • 2.1 DEFINITION 16
  • 2.2 SCOPE OF THE STUDY 16
  • 2.3 RESEARCH OBJECTIVE 16
  • 2.4 MARKET STRUCTURE 16
  • 2.5 ASSUMPTIONS & LIMITATIONS 17

3 RESEARCH METHODOLOGY

  • 3.1 DATA MINING 18
  • 3.2 SECONDARY RESEARCH 19
  • 3.3 PRIMARY RESEARCH 20
  • 3.4 BREAKDOWN OF PRIMARY RESPONDENTS 21
  • 3.5 FORECASTING TECHNIQUES 21
  • 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 22
    • 3.6.1 BOTTOM-UP APPROACH 23
    • 3.6.2 TOP-DOWN APPROACH 23
  • 3.7 DATA TRIANGULATION 24
  • 3.8 VALIDATION 24

4 MARKET DYNAMICS

  • 4.1 OVERVIEW 25
  • 4.2 DRIVERS 26
    • 4.2.1 INCREASING NOVEL DRUG APPROVALS 26
    • 4.2.2 INCREASING PREVALENCE OF HEART DISEASES 26
  • 4.3 RESTRAINT 27
    • 4.3.1 HIGH COST OF HERG SCREENING PRODUCTS 27
  • 4.4 OPPORTUNITY 28
    • 4.4.1 UNTAPPED MARKETS 28
  • 4.5 IMPACT OF CORONAVIRUS (COVID)-19 28
    • 4.5.1 OVERVIEW 28
    • 4.5.2 IMPACT ON PLAYERS 28
    • 4.5.3 IMPACT ON CLINICAL TRIALS 28

5 MARKET FACTOR ANALYSIS

  • 5.1 SUPPLY CHAIN ANALYSIS 29
    • 5.1.1 R&D AND DESIGNING 29
    • 5.1.2 MANUFACTURING 30
    • 5.1.3 DISTRIBUTION 30
    • 5.1.4 MARKETING & SALES 30
    • 5.1.5 POST-SALES MONITORING 30
  • 5.2 PORTER'S FIVE FORCES MODEL 30
    • 5.2.1 BARGAINING POWER OF SUPPLIERS 31
    • 5.2.2 BARGAINING POWER OF BUYERS 31
    • 5.2.3 THREAT OF NEW ENTRANTS 32
    • 5.2.4 THREAT OF SUBSTITUTES 32
    • 5.2.5 RIVALRY 32
  • 5.3 TECHNOLOGICAL TRENDS IN GLOBAL HERG SCREENING MARKET 32
    • 5.3.1 INCREASING TREND OF OUTSOURCING HERG SERVICES 32
    • 5.3.2 ADVENT OF PATCH CLAMP ASSAY 33
    • 5.3.3 STRATEGIC INITIATIVES BY PLAYERS IN THE MARKET 33
  • 5.4 CUSTOMER NEED ANALYSIS 33
    • 5.4.1 OVERVIEW 33
    • 5.4.2 CLINICAL TRIAL FOR HERG SCREENING 33
    • 5.4.3 CAUSE AND EFFECT ANALYSIS 34

6 GLOBAL HERG SCREENING MARKET, BY TYPE

  • 6.1 OVERVIEW 35
  • 6.2 GENE KCNH2 36
  • 6.3 MUTANT KCNH2 36

7 GLOBAL HERG SCREENING MARKET, BY ION CHANNEL

  • 7.1 OVERVIEW 37
  • 7.2 VOLTAGE-GATED ION CHANNEL 39
  • 7.3 LIGAND-GATED ION CHANNEL 39
  • 7.4 OTHERS 40

8 GLOBAL HERG SCREENING MARKET, BY APPLICATION

  • 8.1 OVERVIEW 41
  • 8.2 ANTIARRHYTHMIC 43
  • 8.3 ANTIPSYCHOTIC 43
  • 8.4 ANTIBIOTIC 43
  • 8.5 OTHERS 44

9 GLOBAL HERG SCREENING MARKET, BY REGION

  • 9.1 OVERVIEW 45
  • 9.2 AMERICAS 47
    • 9.2.1 NORTH AMERICA 49
      • 9.2.1.1 US 51
      • 9.2.1.2 CANADA 52
    • 9.2.2 LATIN AMERICA 53
  • 9.3 EUROPE 54
    • 9.3.1 WESTERN EUROPE 56
      • 9.3.1.1 GERMANY 58
      • 9.3.1.2 FRANCE 59
      • 9.3.1.3 UK 60
      • 9.3.1.4 ITALY 61
      • 9.3.1.5 SPAIN 62
      • 9.3.1.6 REST OF WESTERN EUROPE 63
    • 9.3.2 EASTERN EUROPE 64
  • 9.4 ASIA-PACIFIC 65
    • 9.4.1 CHINA 67
    • 9.4.2 JAPAN 68
    • 9.4.3 INDIA 69
    • 9.4.4 AUSTRALIA 70
    • 9.4.5 SOUTH KOREA 71
    • 9.4.6 REST OF ASIA-PACIFIC 72
  • 9.5 MIDDLE EAST & AFRICA 73
    • 9.5.1 MIDDLE EAST 75
    • 9.5.2 AFRICA 76

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW 77
  • 10.2 MARKET RANKING ANALYSIS 77
  • 10.3 COMPETITIVE BENCHMARKING 78
  • 10.4 KEY DEVELOPMENTS AND GROWTH STRATEGIES 79
    • 10.4.1 PARTNERSHIP 79
    • 10.4.2 ACQUISITIONS 80
    • 10.4.3 COLLABORATION 80
  • 10.5 MAJOR PLAYERS FINANCIAL MATRIX & MARKET RATIO 81
    • 10.5.1 SALES & OPERATING PROFIT MARGIN 81
    • 10.5.2 R&D EXPENDITURE 81

11 COMPANY PROFILES

  • 11.1 THERMO FISHER SCIENTIFIC INC. 82
    • 11.1.1 COMPANY OVERVIEW 82
    • 11.1.2 FINANCIAL OVERVIEW 82
    • 11.1.3 PRODUCTS/SERVICES OFFERED 83
    • 11.1.4 KEY DEVELOPMENTS 83
    • 11.1.5 SWOT ANALYSIS 83
    • 11.1.6 KEY STRATEGIES 83
  • 11.2 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. 84
    • 11.2.1 COMPANY OVERVIEW 84
    • 11.2.2 FINANCIAL OVERVIEW 84
    • 11.2.3 PRODUCTS/SERVICES OFFERED 85
    • 11.2.4 KEY DEVELOPMENTS 85
    • 11.2.5 SWOT ANALYSIS 86
    • 11.2.6 KEY STRATEGIES 86
  • 11.3 MERCK KGAA 87
    • 11.3.1 COMPANY OVERVIEW 87
    • 11.3.2 FINANCIAL OVERVIEW 87
    • 11.3.3 PRODUCTS/SERVICES OFFERED 88
    • 11.3.4 KEY DEVELOPMENTS 88
    • 11.3.5 SWOT ANALYSIS 88
    • 11.3.6 KEY STRATEGIES 88
  • 11.4 EUROFINS DISCOVERX CORPORATION 89
    • 11.4.1 COMPANY OVERVIEW 89
    • 11.4.2 FINANCIAL OVERVIEW 89
    • 11.4.3 PRODUCTS/SERVICES OFFERED 90
    • 11.4.4 KEY DEVELOPMENTS 90
    • 11.4.5 SWOT ANALYSIS 90
    • 11.4.6 KEY STRATEGIES 91
  • 11.5 ABCAM PLC. 92
    • 11.5.1 COMPANY OVERVIEW 92
    • 11.5.2 FINANCIAL OVERVIEW 92
    • 11.5.3 PRODUCTS/SERVICES OFFERED 93
    • 11.5.4 KEY DEVELOPMENTS 93
    • 11.5.5 SWOT ANALYSIS 94
    • 11.5.6 KEY STRATEGIES 94
  • 11.6 CYPROTEX LIMITED 95
    • 11.6.1 COMPANY OVERVIEW 95
    • 11.6.2 FINANCIAL OVERVIEW 95
    • 11.6.3 PRODUCTS/SERVICES OFFERED 95
    • 11.6.4 KEY DEVELOPMENTS 95
    • 11.6.5 SWOT ANALYSIS 96
    • 11.6.6 KEY STRATEGIES 96
  • 11.7 B'SYS GMBH 97
    • 11.7.1 COMPANY OVERVIEW 97
    • 11.7.2 FINANCIAL OVERVIEW 97
    • 11.7.3 PRODUCTS/SERVICES OFFERED 97
    • 11.7.4 KEY DEVELOPMENTS 97
    • 11.7.5 SWOT ANALYSIS 98
    • 11.7.6 KEY STRATEGIES 98
  • 11.8 CREATIVE BIOARRAY 99
    • 11.8.1 COMPANY OVERVIEW 99
    • 11.8.2 FINANCIAL OVERVIEW 99
    • 11.8.3 PRODUCTS/SERVICES OFFERED 99
    • 11.8.4 KEY DEVELOPMENTS 99
    • 11.8.5 SWOT ANALYSIS 100
    • 11.8.6 KEY STRATEGIES 100
  • 11.9 METRION BIOSCIENCES LTD 101
    • 11.9.1 COMPANY OVERVIEW 101
    • 11.9.2 FINANCIAL OVERVIEW 101
    • 11.9.3 PRODUCTS/SERVICES OFFERED 101
    • 11.9.4 KEY DEVELOPMENTS 101
    • 11.9.5 SWOT ANALYSIS 102
    • 11.9.6 KEY STRATEGIES 102
  • 11.10 AURORA BIOMED INC. 103
    • 11.10.1 COMPANY OVERVIEW 103
    • 11.10.2 FINANCIAL OVERVIEW 103
    • 11.10.3 PRODUCTS/SERVICES OFFERED 103
    • 11.10.4 KEY DEVELOPMENTS 103
    • 11.10.5 SWOT ANALYSIS 104
    • 11.10.6 KEY STRATEGIES 104

12 APPENDIX

  • 12.1 REFERENCES 105
  • 12.2 RELATED REPORTS 105

LIST OF TABLES

  • TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 17
  • TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 20
  • TABLE 3 GLOBAL HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 36
  • TABLE 4 GLOBAL HERG SCREENING MARKET, FOR GENE KCNH2, BY REGION, 2022-2030 (USD MILLION) 36
  • TABLE 5 GLOBAL HERG SCREENING MARKET, FOR MUTANT KCNH2, BY REGION, 2022-2030 (USD MILLION) 36
  • TABLE 6 GLOBAL HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 38
  • TABLE 7 GLOBAL HERG SCREENING MARKET, FOR VOLTAGE-GATED ION CHANNEL, BY REGION, 2022-2030 (USD MILLION) 39
  • TABLE 8 GLOBAL HERG SCREENING MARKET, FOR LIGAND-GATED ION CHANNEL, BY REGION, 2022-2030 (USD MILLION) 39
  • TABLE 9 GLOBAL HERG SCREENING MARKET, FOR OTHERS, BY REGION, 2022-2030 (USD MILLION) 40
  • TABLE 10 GLOBAL HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 42
  • TABLE 11 GLOBAL HERG SCREENING MARKET, FOR ANTIARRHYTHMIC, BY REGION, 2022-2030 (USD MILLION) 43
  • TABLE 12 GLOBAL HERG SCREENING MARKET, FOR ANTIPSYCHOTIC, BY REGION, 2022-2030 (USD MILLION) 43
  • TABLE 13 GLOBAL HERG SCREENING MARKET, FOR ANTIBIOTIC, BY REGION, 2022-2030 (USD MILLION) 43
  • TABLE 14 GLOBAL HERG SCREENING MARKET, FOR OTHERS, BY REGION, 2022-2030 (USD MILLION) 44
  • TABLE 15 GLOBAL HERG SCREENING MARKET, BY REGION, 2022-2030 (USD MILLION) 46
  • TABLE 16 AMERICAS: HERG SCREENING MARKET, BY REGION, 2022-2030 (USD MILLION) 47
  • TABLE 17 AMERICAS: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 47
  • TABLE 18 AMERICAS: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 48
  • TABLE 19 AMERICAS: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 48
  • TABLE 20 NORTH AMERICA: HERG SCREENING MARKET, BY COUNTRY, 2022-2030 (USD MILLION) 49
  • TABLE 21 NORTH AMERICA: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 49
  • TABLE 22 NORTH AMERICA: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 50
  • TABLE 23 NORTH AMERICA: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 50
  • TABLE 24 US: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 51
  • TABLE 25 US: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 51
  • TABLE 26 US: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 51
  • TABLE 27 CANADA: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 52
  • TABLE 28 CANADA: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 52
  • TABLE 29 CANADA: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 52
  • TABLE 30 LATIN AMERICA: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 53
  • TABLE 31 LATIN AMERICA: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 53
  • TABLE 32 LATIN AMERICA: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 53
  • TABLE 33 EUROPE: HERG SCREENING MARKET, BY REGION, 2022-2030 (USD MILLION) 54
  • TABLE 34 EUROPE: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 54
  • TABLE 35 EUROPE: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 55
  • TABLE 36 EUROPE: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 55
  • TABLE 37 WESTERN EUROPE: HERG SCREENING MARKET, BY COUNTRY, 2022-2030 (USD MILLION) 56
  • TABLE 38 WESTERN EUROPE: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 56
  • TABLE 39 WESTERN EUROPE: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 57
  • TABLE 40 WESTERN EUROPE: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 57
  • TABLE 41 GERMANY: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 58
  • TABLE 42 GERMANY: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 58
  • TABLE 43 GERMANY: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 58
  • TABLE 44 FRANCE: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 59
  • TABLE 45 FRANCE: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 59
  • TABLE 46 FRANCE: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 59
  • TABLE 47 UK: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 60
  • TABLE 48 UK: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 60
  • TABLE 49 UK: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 60
  • TABLE 50 ITALY: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 61
  • TABLE 51 ITALY: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 61
  • TABLE 52 ITALY: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 61
  • TABLE 53 SPAIN: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 62
  • TABLE 54 SPAIN: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 62
  • TABLE 55 SPAIN: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 62
  • TABLE 56 REST OF WESTERN EUROPE: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 63
  • TABLE 57 REST OF WESTERN EUROPE: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 63
  • TABLE 58 REST OF WESTERN EUROPE: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 63
  • TABLE 59 EASTERN EUROPE: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 64
  • TABLE 60 EASTERN EUROPE: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 64
  • TABLE 61 EASTERN EUROPE: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 64
  • TABLE 62 ASIA-PACIFIC: HERG SCREENING MARKET, BY COUNTRY, 2022-2030 (USD MILLION) 65
  • TABLE 63 ASIA-PACIFIC: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 65
  • TABLE 64 ASIA-PACIFIC: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 66
  • TABLE 65 ASIA-PACIFIC: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 66
  • TABLE 66 CHINA: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 67
  • TABLE 67 CHINA: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 67
  • TABLE 68 CHINA: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 67
  • TABLE 69 JAPAN: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 68
  • TABLE 70 JAPAN: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 68
  • TABLE 71 JAPAN: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 68
  • TABLE 72 INDIA: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 69
  • TABLE 73 INDIA: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 69
  • TABLE 74 INDIA: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 69
  • TABLE 75 AUSTRALIA: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 70
  • TABLE 76 AUSTRALIA: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 70
  • TABLE 77 AUSTRALIA: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 70
  • TABLE 78 SOUTH KOREA: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 71
  • TABLE 79 SOUTH KOREA: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 71
  • TABLE 80 SOUTH KOREA: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 71
  • TABLE 81 REST OF ASIA-PACIFIC: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 72
  • TABLE 82 REST OF ASIA-PACIFIC: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 72
  • TABLE 83 REST OF ASIA-PACIFIC: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 72
  • TABLE 84 MIDDLE EAST & AFRICA: HERG SCREENING MARKET, BY REGION, 2022-2030 (USD MILLION) 73
  • TABLE 85 MIDDLE EAST & AFRICA: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 73
  • TABLE 86 MIDDLE EAST & AFRICA: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 74
  • TABLE 87 MIDDLE EAST & AFRICA: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 74
  • TABLE 88 MIDDLE EAST: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 75
  • TABLE 89 MIDDLE EAST: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 75
  • TABLE 90 MIDDLE EAST: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 75
  • TABLE 91 AFRICA: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 76
  • TABLE 92 AFRICA: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 76
  • TABLE 93 AFRICA: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 76
  • TABLE 94 TOP PLAYERS IN THE GLOBAL HERG SCREENING MARKET 77
  • TABLE 95 PARTNERSHIP: GLOBAL HERG SCREENING MARKET 79
  • TABLE 96 ACQUISITIONS: GLOBAL HERG SCREENING MARKET 80
  • TABLE 97 COLLABORATION: GLOBAL HERG SCREENING MARKET 80
  • TABLE 98 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED 83
  • TABLE 99 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: PRODUCTS/SERVICES OFFERED 85
  • TABLE 100 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: KEY DEVELOPMENTS 85
  • TABLE 101 MERCK KGAA: PRODUCTS/SERVICES OFFERED 88
  • TABLE 102 EUROFINS DISCOVERX CORPORATION: PRODUCTS/SERVICES OFFERED 90
  • TABLE 103 EUROFINS DISCOVERX CORPORATION: KEY DEVELOPMENTS 90
  • TABLE 104 ABCAM PLC.: PRODUCTS/SERVICES OFFERED 93
  • TABLE 105 ABCAM PLC.: KEY DEVELOPMENTS 93
  • TABLE 106 CYPROTEX LIMITED: PRODUCTS/SERVICES OFFERED 95
  • TABLE 107 B'SYS GMBH: PRODUCTS/SERVICES OFFERED 97
  • TABLE 108 CREATIVE BIOARRAY: PRODUCTS/SERVICES OFFERED 99
  • TABLE 109 METRION BIOSCIENCES LTD: PRODUCTS/SERVICES OFFERED 101
  • TABLE 110 AURORA BIOMED INC.: PRODUCTS/SERVICES OFFERED 103

LIST OF FIGURES

  • FIGURE 1 MARKET SYNOPSIS 14
  • FIGURE 2 MARKET ATTRACTIVENESS ANALYSIS, BY REGION, 2022 15
  • FIGURE 3 GLOBAL HERG SCREENING MARKET: STRUCTURE 16
  • FIGURE 4 BOTTOM-UP AND TOP-DOWN APPROACHES 23
  • FIGURE 5 MARKET DYNAMICS: ANALYSIS: GLOBAL HERG SCREENING MARKET 25
  • FIGURE 6 INCREASING NOVEL DRUGS APPROVALS 26
  • FIGURE 7 DRIVER IMPACT ANALYSIS 27
  • FIGURE 8 RESTRAINT IMPACT ANALYSIS 27
  • FIGURE 9 SUPPLY CHAIN ANALYSIS: HERG SCREENING MARKET 29
  • FIGURE 10 PORTER'S FIVE FORCES ANALYSIS: GLOBAL HERG SCREENING MARKET 31
  • FIGURE 11 GLOBAL HERG SCREENING MARKET SHARE, BY TYPE, 2022 (%) 35
  • FIGURE 12 GLOBAL HERG SCREENING MARKET, BY TYPE, 2022 & 2030 (USD MILLION) 35
  • FIGURE 13 GLOBAL HERG SCREENING MARKET SHARE, BY ION CHANNEL, 2022 (%) 38
  • FIGURE 14 GLOBAL HERG SCREENING MARKET, BY ION CHANNEL, 2022 & 2030 (USD MILLION) 38
  • FIGURE 15 GLOBAL HERG SCREENING MARKET SHARE, BY APPLICATION, 2022 (%) 42
  • FIGURE 16 GLOBAL HERG SCREENING MARKET, BY APPLICATION, 2022 & 2030 (USD MILLION) 42
  • FIGURE 17 GLOBAL HERG SCREENING MARKET SHARE, BY REGION, 2022 (%) 45
  • FIGURE 18 GLOBAL HERG SCREENING MARKET, BY REGION, 2022 & 2030 (USD MILLION) 46
  • FIGURE 19 AMERICAS: HERG SCREENING MARKET SHARE, BY REGION, 2022 (%) 47
  • FIGURE 20 NORTH AMERICA: HERG SCREENING MARKET SHARE, BY COUNTRY, 2022 (%) 49
  • FIGURE 21 EUROPE: HERG SCREENING MARKET SHARE, BY REGION, 2022 (%) 54
  • FIGURE 22 WESTERN EUROPE: HERG SCREENING MARKET SHARE, BY COUNTRY, 2022 (%) 56
  • FIGURE 23 ASIA-PACIFIC: HERG SCREENING MARKET SHARE, BY COUNTRY, 2022 (%) 65
  • FIGURE 24 MIDDLE EAST & AFRICA: HERG SCREENING MARKET SHARE, BY REGION, 2022 (%) 73
  • FIGURE 25 BENCHMARKING OF MAJOR COMPETITORS 78
  • FIGURE 26 HERG SCREENING MARKET, COMPETITIVE LANDSCAPE (% SHARE) 79
  • FIGURE 27 SALES & OPERATING PROFIT MARGIN, 2022 81
  • FIGURE 28 R&D EXPENDITURE, 2022 81
  • FIGURE 29 THERMO FISHER SCIENTIFIC INC.: FINANCIAL OVERVIEW SNAPSHOT 82
  • FIGURE 30 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS 83
  • FIGURE 31 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: FINANCIAL OVERVIEW SNAPSHOT 84
  • FIGURE 32 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: SWOT ANALYSIS 86
  • FIGURE 33 MERCK KGAA: FINANCIAL OVERVIEW 87
  • FIGURE 34 MERCK KGAA: SWOT ANALYSIS 88
  • FIGURE 35 EUROFINS DISCOVERX CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 89
  • FIGURE 36 EUROFINS DISCOVERX CORPORATION: SWOT ANALYSIS 90
  • FIGURE 37 ABCAM PLC.: FINANCIAL OVERVIEW SNAPSHOT 92
  • FIGURE 38 ABCAM PLC.: SWOT ANALYSIS 94
  • FIGURE 39 CYPROTEX LIMITED: SWOT ANALYSIS 96
  • FIGURE 40 B'SYS GMBH: SWOT ANALYSIS 98
  • FIGURE 41 CREATIVE BIOARRAY: SWOT ANALYSIS 100
  • FIGURE 42 METRION BIOSCIENCES LTD.: FINANCIAL OVERVIEW SNAPSHOT 101
  • FIGURE 43 METRION BIOSCIENCES LTD.: SWOT ANALYSIS 102
  • FIGURE 44 AURORA BIOMED INC.: SWOT ANALYSIS 104